Changes in Topical Corticosteroid Dispensing Patterns Following Specialist Consultation in Patients with Atopic Dermatitis: A Two-year Longitudinal Study
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0783Keywords:
atopic dermatitis, eczema, topical corticosteroidsDownloads
References
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020; 396: 345–360. DOI: https://doi.org/10.1016/S0140-6736(20)31286-1
Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M, et al. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol 2020; 34: 2717–2744. DOI: https://doi.org/10.1111/jdv.16892
Stacey SK, McEleney M. Topical Corticosteroids: Choice and Application. Am Fam Physician 2021; 103: 337–343.
Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 2012; 26: 1045–1060. DOI: https://doi.org/10.1111/j.1468-3083.2012.04635.x
Simpson EL, Guttman-Yassky E, Margolis DJ, Feldman SR, Qureshi A, Hata T, et al. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis. JAMA Dermatol 2018; 154: 903–912. DOI: https://doi.org/10.1001/jamadermatol.2018.1572
Singh I, Chat VS, Uy A, Borba A, Chen AY, Armstrong AW. Who sees you matters: a population study examining topical corticosteroid prescribing patterns between primary care providers and dermatologists for atopic dermatitis. J Dermatolog Treat 2022; 33: 1507–1510. DOI: https://doi.org/10.1080/09546634.2020.1836311
Bowie AC, Tadrous M, Thiruchelvam D, Ivers NM, Mohan T, Tu K, et al. A comparison of family physician and dermatologist topical corticosteroid prescriptions: A population-based cross-sectional study. J Am Acad Dermatol 2023; 88: 1291–1299. DOI: https://doi.org/10.1016/j.jaad.2023.01.036
Lambrechts L, Gilissen L, Morren MA. Topical Corticosteroid Phobia Among Healthcare Professionals Using the TOPICOP Score. Acta Derm Venereol 2019; 99: 1004–1008. DOI: https://doi.org/10.2340/00015555-3220
Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy AM, Nguyen JM, Leux C, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol 2011; 165: 808–814. DOI: https://doi.org/10.1111/j.1365-2133.2011.10449.x
Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142: 931–936. DOI: https://doi.org/10.1046/j.1365-2133.2000.03473.x
Danielsen AK, Frølunde AS, Heilskov S, Deleuran M, Laust Thomsen J, Vestergaard C. Treatment and referral patterns of patients with atopic dermatitis from the Danish primary care system to the tertiary care system. JEADV Clinical Practice 2024; 3: 1005–1015. DOI: https://doi.org/10.1002/jvc2.374
Gustavsen HE, Gjersvik P. Topical corticosteroid phobia among parents of children with atopic dermatitis in a semirural area of Norway. J Eur Acad Dermatol Venereol 2016; 30: 168. DOI: https://doi.org/10.1111/jdv.12670
Published
How to Cite
License
Copyright (c) 2026 Fatema Shahin, Anne Sofie Frølunde, Christian Vestergaard
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
